Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681224 · ClinicalTrials.gov registry record · NA
TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest
A NA study, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02681224: Completed NA study, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
NCT02681224 is a NA study that has completed, run by Goldman, Butterwick, Fitzpatrick and Groff. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02681224, a NA study, has completed, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
A single site, double-blind, randomized, placebo-controlled, clinical study comparing the difference between a novel healing gel and a placebo gel on post laser-resurfacing chests.
Interventions
- OTHER TR987 Gel with Silon Bandage
- OTHER TR987 without Silon Bandage
- OTHER Placebo Gel with Silon Bandage
- OTHER Placebo Gel without Silon Bandage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02681224 record still lists
NCT02681224 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which TR987 Gel with Silon Bandage is the first listed.
NCT02681224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02681224 about?
NCT02681224 is a clinical study titled "TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest". A single site, double-blind, randomized, placebo-controlled, clinical study comparing the difference between a novel healing gel and a placebo gel on post laser-resurfacing chests.
What is the current status of trial NCT02681224?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2015-09. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02681224?
The interventions under investigation include: TR987 Gel with Silon Bandage (OTHER), TR987 without Silon Bandage (OTHER), Placebo Gel with Silon Bandage (OTHER), Placebo Gel without Silon Bandage (OTHER).
Who is sponsoring clinical trial NCT02681224?
This trial is sponsored by Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02681224's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia